Regulatory status on the role of in vitro dissolution testing in quality control and biopharmaceutics in Europe
Risk analysis in bioequivalence and biowaiver decisions
Analysis of level A in vitro–in vivo correlations for an extended-release formulation with limited bioavailability
Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro
Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers